
Eisai, Biogen’s Alzheimer’s drug price should not dent demand
2/2 © Reuters. FILE PHOTO: A sign marks a Biogen facility in Cambridge, Massachusetts, U.S. January 26, 2017. REUTERS/Brian Snyder 2/2 (Reuters) – The $26,500-per-year price tag for Eisai Co (OTC:) Ltd and Biogen Inc […]